Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature
We report the case of a 56-year old male with severe plaque psoriasis that was successfully treated with ixekizumab, a new anti interleukin (IL)-17 monoclonal antibody. During the first months of treatment he developed a lentiginous eruption in the sites of rapidly resolving plaques. Biopsy and immu...
Saved in:
Main Authors: | Pablo Santa María (Author), Fernando Valenzuela (Author), Claudia Morales (Author), Raul De la Fuente (Author), Roberto Cullen (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Eruptive lentiginosis in resolving psoriatic plaques
by: Robert Micieli, BSc, et al.
Published: (2018) -
Emerging targeted therapies for plaque psoriasis – impact of ixekizumab
by: Kazemi T, et al.
Published: (2017) -
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Ren V, et al.
Published: (2013) -
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017) -
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
by: Hanley TL, et al.
Published: (2017)